OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer' (Q27701037)

1

0 references

Yuko Tsutsumi

2

0 references

Mototsugu Yamada

3

0 references

Kenji Suzuki

4

0 references

Takashi Watanabe

5

0 references

Takao Abe

6

0 references

Takeshi Furuuchi

7

0 references

Seiichi Inamura

8

0 references

Yoshiaki Sakamaki

9

0 references

Nakako Mitsuhashi

10

0 references

Takashi Ida

11

0 references

David M Livermore

Journal of Antimicrobial Chemotherapy

12

0 references

language of work or name

English

0 references

publication date

October 2015

0 references

published in

0 references

volume

70

0 references

page(s)

2779-86

0 references

issue

10

0 references

cites work

Proliferation and significance of clinically relevant β-lactamases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Updated functional classification of beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

High prevalence of fecal carriage of extended spectrum β-lactamase/AmpC-producing Enterobacteriaceae in cats and dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-Producing Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Activity of carbapenems with ME1071 (disodium 2,3-diethylmaleate) against Enterobacteriaceae and Acinetobacter spp. with carbapenemases, including NDM enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

MOLREP: an Automated Program for Molecular Replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

2-Bromo-pyridine-3-carboxylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Inhibition of Cell Division of Escherichia coli by a New Synthetic Penicillin, Piperacillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC -Lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Avibactam and Class C -Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Inhibition of penicillin-binding protein 3 of Escherichia coli K-12. Effects upon growth, viability and outer membrane barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Why spherical Escherichia coli dies: the inside story

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

The Rcs phosphorelay is a cell envelope stress response activated by peptidoglycan stress and contributes to intrinsic antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Kinetics of avibactam inhibition against Class A, C, and D β-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Amdinocillin: interaction with other beta-lactam antibiotics for gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia coli by some beta-lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166

ppGpp concentration, growth without PBP2 activity, and growth-rate control in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV166